Em P David Back
Professor Pharmacology & Therapeutics
- +44 (0)151 794 5547
- Work email D.J.Back@liverpool.ac.uk
Research
Research Group Membership
Research Grants
Pharmacologic strategies to use the levonorgestrel implant in HIV-infected women
NATIONAL INSTITUTES OF HEALTH (USA)
December 2015 - November 2020
Protease inhibitors and drug disposition (PROCOM/FORTE Trial)
MEDICAL RESEARCH COUNCIL
October 1997 - December 2003
Pharmacogenetic and pharmacokinetic studies.
MONUMENT TRUST (UK)
August 2005 - April 2011
Modelling adherence, pharmacokinetics and treatment outcomes in HIV therapy.
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)
September 2003 - September 2008
Therapeutic Drug Monitoring of Anti-HIV Drugs.
MONUMENT TRUST (UK)
October 1999 - September 2003
Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.
JOINT CLINICAL RESEARCH CENTRE (UGANDA)
September 2010 - December 2012
Effects within HAART on markers of adipose function.
PENNINE ACUTE HOSPITALS NHS TRUST (UK)
December 2005 - June 2009
The pharmacology of HIV treatment failure.
BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)
October 2001 - December 2008
Effects of NRTIs on adipose function.
PENNINE ACUTE HOSPITALS NHS TRUST (UK)
January 2006 - June 2009
TAILoR (TelmisArtan and InsuLin Resistance in HIV): A dose-ranging Phase II randomised open trial of telmistartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on Combination Antiretroviral Therapy (CART)
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
January 2012 - February 2020
A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapy.
NATIONAL INSTITUTES OF HEALTH (USA)
November 2013 - December 2016
Modulation of TB-HIV drug interaction by host genetic influences
MEDICAL RESEARCH COUNCIL
July 2010 - June 2013
Sub contractual agreement for multiple plasma sample tests agreement
ST STEPHEN'S AIDS TRUST (UK)
August 2009 - July 2012
Population pharmacokinetic-pharmacodynamic modelling to optimise treatments for HIV,TB and malaria
WELLCOME TRUST (UK)
November 2008 - October 2012
Detection of minority strains of HIV harbouring drug resistance.
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)
October 2002 - September 2005
Therapeutic Drug Monitoring for HIV Protease Inhibitors.
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
February 2000 - January 2003
Influx and efflux transporters: a possible pharmacological determinant of HIV treatment failure.
AVERT (UK)
September 2000 - August 2003
Understanding cellular resistance - an important link to understanding virological resistance.
AVERT (UK)
September 2001 - August 2004
Assessment of TMC-278LA
MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION (MWRIF) (USA)
January 2012 - March 2017
Liverpool Oxford Tropical Link (LOTLINK) in Clinical Pharmacology.
WELLCOME TRUST (UK)
January 2002 - December 2006
A real time polymerase chain reaction machine and technical support.
MONUMENT TRUST (UK)
December 2003 - July 2006
The Use of 'virtual' Inhibitory Quotients to Optimise HIV Treatment.
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
January 2003 - December 2009
St Stephens Aids Trust - SSAT trials
ST STEPHEN'S AIDS TRUST (UK)
April 2010 - March 2020
HIV Research Trust Award for M Lamorde
HIV RESEARCH TRUST (UK)
May 2009 - July 2009
Evaluation of the steady state pharmakinectics of second line antiretroviral drugs when administered under different meal conditions in HIV-infected Ugandan adults
INFECTIOUS DISEASES INSTITUTE (UGANDA)
September 2010 - December 2011
Bioanalytical facility for drugs and small molecules
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)
July 2010 - June 2011